Advertisement

Topics

Onconova Therapeutics Inc. Company Profile

08:44 EDT 19th June 2018 | BioPortfolio

Onconova, a privately held Delaware Corporation, is developing innovative products for combating cancer. We are creating novel Solutions for Oncology by combining conventional pharmaceutical science (a small molecule approach) with the latest genomic and genetic technologies for drug discovery and development

Location

P.O. Box 7693
Princeton
New Jersey
8543
United States of America

Contact

Phone: (609) 844-7735
Fax: 609) 844-7736
Email: info@onconova.com


News Articles [789 Associated News Articles listed on BioPortfolio]

Deals this week: Onconova Therapeutics, Humorigin Biotechnology, Zosano Pharma

Onconova Therapeutics Inc plans to raise $13.66m through a public offering of 8.65 million shares priced at $1.58 a unit....Read More... The post Deals this week: Onconova Therapeutics, Humorigin Biot...

Anika Therapeutics (ANIK) versus Onconova Therapeutics (ONTX) Financial Survey

Anika Therapeutics and Onconova Therapeutics are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earn...

Onconova presents data on myelodysplastic syndromes candidate rigosertib

Preliminary data from Onconova Therapeutics' early-stage trial to assess the efficacy of its lead candidate rigosertib combin -More- 

HanX gets Chinese rights to Onconova's ON123300

Onconova Therapeutics Inc. granted HanX Biopharmaceuticals Inc. rights to develop and sell its preclinical cancer project ON123300 in China.

Active-Investors: Wired News - Onconova Signs License and Collaborative Development Agreement with HanX Biopharma for ON 123300

Stock Monitor: Sinovac Biotech Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 21, 2017 / Active-Investors.com has just released a free report on Onconova Therapeutics, Inc. (NASDAQ: ONT...

Onconova sells shares and pre-funded warrants; nets $8.1mm

Cancer drug developer Onconova Therapeutics Inc. publicly sold 5.7mm units at $1.01 for net proceeds of $5.36mm. The units consisted of one common share and a one-year warrant to buy 0.1 share of Seri...

Onconova sells shares and pre-funded warrants; nets $9.3mm

Cancer drug developer Onconova Therapeutics Inc. publicly sold 7mm units (including the overallotment) at $1.01 for net proceeds of $6.58mm. The units consisted of one common share and a one-year warr...

Onconova grants Latin American rigosertib rights to Pint Pharma

Onconova Therapeutics Inc. granted Pint Pharma GMBH exclusive rights to sell rigosertib in Latin America.

PubMed Articles [411 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Eyes on New Product Development: Preclinical Research.

Eyes on New Product Development: Preclinical Research.

Clinical Trials [144 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1236 Associated Companies listed on BioPortfolio]

Onconova Therapeutics, Inc.

Onconova, based in Newtown, PA and Lawrenceville, NJ, discovers and develops novel patent- protected small molecule therapeutic agents for cancer, radiation protection and hematol...

Onconova Therapeutics Inc.

Onconova, a privately held Delaware Corporation, is developing innovative products for combating cancer. We are creating novel Solutions for Oncology by combining conventional pharmaceutical science (...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Onconova Therapeutics Inc." on BioPortfolio

We have published hundreds of Onconova Therapeutics Inc. news stories on BioPortfolio along with dozens of Onconova Therapeutics Inc. Clinical Trials and PubMed Articles about Onconova Therapeutics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Onconova Therapeutics Inc. Companies in our database. You can also find out about relevant Onconova Therapeutics Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record